Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Despite its use for decades all over the world, the exact mechanism of action of paracetamol is not fully understood and essentially involves a combination of hypotheses. It is known to have an effect via the central nervous system, and of the many mechanisms proposed, one hypothesis is that it may have indirectly activate CB1 (cannabinoid) receptors, through its novel metabolite AM404.
This study aims to elucidate cerebrospinal levels of paracetamol and to measure the concentration of its metabolites, including AM404 in CSF. This may, in turn, give us useful information on the mechanism of action of paracetamol.
Patients undergoing spinal blockade for urological surgery were administered 1g paracetamol intravenously at varying intervals prior to spinal anaesthesia, at which time 5mls of cerebrospinal fluid and 10mls of blood were sampled, and analysed for concentrations of paracetamol, paracetamol glucuronide, paracetamol sulphate, and AM404, a known endocannabinoid reuptake inhibitor, and metabolite of paracetamol.
Paracetamol readily penetrates into the cerebrospinal fluid in animal studies and in children. This could account for the rapid central analgesic and antipyretic action of intravenous paracetamol however this remains to be studied in adults. AM404 has never before been identified in humans, and its presence in CSF following paracetamol supports the hypothesis of a central mechanism of action of paracetamol via AM404.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Sampling at approx 15 minutes | Active Comparator | Plasma and CSF samples to be taken at 15 minutes post administration of intravenous paracetamol |
|
| Sampling at approx 30 minutes | Active Comparator | Plasma and CSF samples to be taken at 30 minutes post administration of intravenous paracetamol |
|
| Sampling at approx 120minutes | Active Comparator | Plasma and CSF samples to be taken at 120 minutes post administration of intravenous paracetamol |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Administration of paracetamol | Drug | Administration of 1g intravenous paracetamol |
|
| Measure | Description | Time Frame |
|---|---|---|
| Measurement of AM404 in CSF | AM404 is a metabolite of paracetamol thought to be formed in the brain. | 5-211 minutes post-administration of paracetamol |
| Measure | Description | Time Frame |
|---|---|---|
| Measurement of paracetamol in plasma and CSF | Concentrations of paracetamol measured in plasma and CSF following intravenous paracetamol administration. | 5-211 minutes post administration of paracetamol |
| Measurement of paracetamol glucuronide and sulphate conjugates in plasma and CSF. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Vivek Mehta, MD | Pain and Anaesthesia Research Centre, Barts Health NHS Trust | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| St Bartholomew's Hospital | London | EC1A | United Kingdom |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
Concentrations of glucuronide and sulphate conjugates of paracetamol measured in plasma and CSF following intravenous paracetamol administration. |
| 5-211 minutes post administration of paracetamol |